Immune Complex Disease

  • Charles G. Cochrane


Various types of injury induced by complexes of antigen and anti-body are reviewed. These include reactions in which antibody reacts with antigens that are fixed in tissues or are soluble but localized at a particular site and reactions that occur following localization of circulating immunologic complexes in a particular tissue from the blood stream. Examples of each are reviewed.

The role of mediation systems in the pathogenesis of immunologic disease is stressed. Two examples of mediation pathways are provided in which a sequence of interacting humoral and cellular reactants is activated by antigen-antibody complex and which is responsible for the injurious consequences.


Immune Complex Polymorphonuclear Leukocyte Glomerular Basement Membrane Internal Elastic Lamina Serum Sickness 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Von Pirquet, C.E.: Allergy. Arch. Intern. Med. 7: 259, 1911CrossRefGoogle Scholar
  2. 2.
    Hawn, C.V.Z. and Janeway, C.A.: Histologic and serological sequences in experimental hypersensitivity. J. Exp. Med. 85: 571, 1947.PubMedCrossRefGoogle Scholar
  3. 3.
    Germuth, F. G.: A comparative histologic and immunologic study in rabbits of induced hypersensitivity of the serum sickness type. J. Exp. Med. 97: 257, 1953.PubMedCrossRefGoogle Scholar
  4. 4.
    Germuth, F.G., and McKinnon, G.E.: Studies on the biological properties of antigen -antibody complexes. I. Anaphylactic shock induced by soluble antigen-antibody complexes in unsensitized normal guinea pigs. Bull0 Johns Hopkins Hosp. 101: 13, 1957.Google Scholar
  5. 5.
    Trapani, I.L., Garvey, J.S. and Campbell, D.: Stimulating action of soluble antigen-antibody complexes on normal guinea pig smooth muscle. Science 127: 700, 1958.PubMedCrossRefGoogle Scholar
  6. 6.
    Ishizaka, K., and Campbell, D.H.: Biological activity of soluble antigen-antibody complexes. I. Skin reactive properties. Proc. Soc. Exp. Biol. Med. 97: 635, 1958.Google Scholar
  7. 7.
    Cochrane, C.G., and Weigle, W.O.: The cutaneous reaction to soluble antigen antibody complexes. A comparison with the Arthus phenomenon. J. Exp. Med. 108: 591, 19570Google Scholar
  8. 8.
    Dixon, F.J.: Characterization of the antibody response. J. Cell. Comp. Physiol. 50: 27, 1957.CrossRefGoogle Scholar
  9. 9.
    Dixon, F.J., Vazquez, J.J., Weigle, W.O., and Cochrane, C.G.: Pathogenesis of serum sickness. Arch. Path. 65: 18, 1958.Google Scholar
  10. 10.
    Unanue, E.R. and Dixon, F.J.: Experimental glomerulonephritis: Immunological events and pathogenetic mechanisms,. Adv. in Immunol. 6: 1, 1967.Google Scholar
  11. 11.
    Cochrane, C.G.: Immunologic tissue injury mediated by neutrophilic leukocytes. Adv. In Immunol. 9: 97, 1968.Google Scholar
  12. 12.
    Cochrane, C.G., and Janoff, A.: The Aruthus reaction: A model of neutrophil and complement mediated injury. In: The Inflammatory Process, Vo. 3, pp. 85–162, 1974.Google Scholar
  13. 13.
    Dixon, F.J.: The role of antigen-antibody complexes in disease. Harvey Lect. 58: 21, 1963.PubMedGoogle Scholar
  14. 14.
    Andres, G.A., Seegal, B.C., Hsu, K.C., Rothenberg, M.S. and Chapeau, M.L.: Electron microscopic studies of experimental nephritis with ferritin-conjugated antibody. Localization of antigen-antibody complexes in rabbit glomeruli following repeated injections of bovine serum albumin. J. Exp. Med. 117: 691, 1963.PubMedCrossRefGoogle Scholar
  15. 15.
    McLean, C.R., Fitzgerald, J.D.L., Younghusband, O.Z. and Hamilton, J.D.: Diffuse glomerulonephritis induced in rabbits by small intravenous injections of horse serum. Arch. Path. 51: 1, 1951.Google Scholar
  16. 16.
    Dixon, F.J., Feldman, J.D., and Vazquez, J.J.: Experimental glomerulonephritis. The pathogenesis of a laboratory model resembling the spectrum of human glomerulonephritis. J. Exp. Med. 113: 899, 1961.PubMedCrossRefGoogle Scholar
  17. 17.
    Bentjens, J.R., O’Connell, D.W., Pawlowski, J.B., Hsu, K.C., and Andres, G.A.: Experimental immune complex disease of the lung. The pathogenesis of a laboratory model resembling certain human interstitial lung disease. J. Exp. Med. 140: 105, 1974.CrossRefGoogle Scholar
  18. 18.
    Cochrane, C.G., Weigle, W.O., and Dixon, F.J.: The role of polymorphonuclear leukocytes in the initiation and cessation of the Arthus vasculitis. J. Exp. Med. 110: 481, 1959.PubMedCrossRefGoogle Scholar
  19. 19.
    Humphrey, J.H.: The mechanism of the Arthus reactions. I. The role of polymorphonuclear leukocytes and platelets in reversed passive Arthus reactions in rabbits. Brit. J. Exp. Path. 36: 268, 1955.Google Scholar
  20. 20.
    Humphrey, J.H.: The mechanism of the Arthus reactions. II. The role of polymorphonuclear leukocytes and platelets in reversed passive Arthus reactions in the guinea pig. Brit. J. Exp. Path. 36:Google Scholar
  21. 21.
    Stetson, C.A.: Similarities in the mechanisms determining the Arthus and Shwartzman phenomena. J.Exp. Med. 94: 347, 1951.Google Scholar
  22. 22.
    DeShazo, C.V., Henson, P. M., and Cochrane, C.G.: Acute immunologic arthritis in rabbits. J. Clin. Invest. 51: 50, 1972.PubMedCrossRefGoogle Scholar
  23. 23.
    DeShazo, C.V., McGrade, M.T., Henson, P.M. and Cochrane, C.G.: The effect of complement depletion on neutrophil migration in acute immunologic nephritis. J. Immunol. 108: 1414, 1972.PubMedGoogle Scholar
  24. 24.
    Kniker, W.T., and Cochrane, C.G.: Pathogenetic factors in vascular lesions of experimental serum sickness. J. Exp. Med. 122: 83, 1965.PubMedCrossRefGoogle Scholar
  25. 25.
    Cochrane, C.G., Unanue, E.R., and Dixon, F.J.: A role of polymorphonuclear leukocytes and complement in nephrotoxic nephritis. J. Exp. Med. 122: 99, 1965.PubMedCrossRefGoogle Scholar
  26. 26.
    Harris, H.: Role of chemotaxis in inflammation. Physiol. Rev. 34: 529, 1954.PubMedGoogle Scholar
  27. 27.
    Buckley, I.K.: Delayed secondary damage and leukocyte chemotaxis following focal aseptic heat injury in vivo. Exp. Molec. Path. 2: 402, 1963.CrossRefGoogle Scholar
  28. 28.
    Hurley, J.V.: Substances promoting luekocyte emigration. In:The Acute Inflammatory Process. N. Y. Acad. Sci.116: 918, 1964.Google Scholar
  29. 29.
    Hurley, J.V., and Spector, W.G.: Endogenous factors responsible for leukocyte emigration in vivo. J. Path. Bact. 82: 403, 1961.PubMedCrossRefGoogle Scholar
  30. 30.
    Ward, P.A., and Cochrane, C.G.: Bound complement and immunologic injury of blood vessels. J. Exp. Med. 121: 215, 1965.PubMedCrossRefGoogle Scholar
  31. 31.
    Boyden, S.: The chemotactic effect of mixtures of antibody and antigen on polymorphonuclear leukocytes. J. Exp. Med. 115: 453, 1962.PubMedCrossRefGoogle Scholar
  32. 32.
    Ward, P.A., Cochrane, C.G., and Muller-Eberhard, H.J.: The role of serum complement in chemotaxis of leukocytes in vitro. J. Exp. Med. 122: 327, 1965.PubMedCrossRefGoogle Scholar
  33. 33.
    Ward, P.A., Cochrane, C.G., and Muller-Eberhard, H.J.: Further studies on the chemotactic factor of complement and its formation in vivo. Immunol. 11: 141, 1966.Google Scholar
  34. 34.
    Bokisch, V.A., Muller-Eberhard, H.J., and Cochrane, C.G.: Isolation of a fragment (C3a) of the third component of human complement containing anaphylatoxin and chemotactic activity and description of an anaphylatoxin inactivator of human serum. J. Exp. Med. 129: 1109, 1969.PubMedCrossRefGoogle Scholar
  35. 35.
    Ward, P.A.: A plasmin-split fragment of C′3′ as a new chemotactic facotr. J. Exp. Med. 126: 189, 1967.PubMedCrossRefGoogle Scholar
  36. 36.
    Shin, H.S., Pickering, R.J., Mayer, M.M., and Cook, C.T.: Guinea pig C′5′. J. Immunol. 101: 813 (abstract), 1968.Google Scholar
  37. 37.
    Ward, P.A., and Newman, L.J.: A neutrophil chemotactic factor from C′5′. J. Immunol. 102: 93, 1969.PubMedGoogle Scholar
  38. 38.
    Cochrane, C.G., and Aikin, B.S.: Polymorphonuclear leukocytes in immunologic reactions. The destruction of vascular basement membrane in vivo and in vitro. J. Exp. Med. 124: 733, 1966.PubMedCrossRefGoogle Scholar
  39. 39.
    Janoff, A., and Zeligs, J.D.: Vascular injury and lysis of basement membrane in vitro by neutral protease of human leukocytes. Science 161: 702, 1968.PubMedCrossRefGoogle Scholar
  40. 40.
    Janoff, A., and Sherer, J.: Mediators of inflammation in leukocyte lysosomes. IX. Elastinolytic activity in granules of human polymorphonuclear leukocytes. J. Exp. Med. 128: 1137, 1968.PubMedCrossRefGoogle Scholar
  41. 41.
    Lazarus, G.S., Brown, R.S., Daniels, J.R., and Fullmer, H.M. H.M.: Human granulocyte collagenase. Science 159: 1483, 1968.CrossRefGoogle Scholar
  42. 42.
    Janoff, A., Schaeffer, S., Scherer, J., and Bran, M.A.: Mediators of inflammation in leukocyte lysosomes. II. Mechanism of action of lysosomal cationic protein upon vascular permeability in the rat. J. Exp. Med. 128: 841, 1965.CrossRefGoogle Scholar
  43. 43.
    Randadive, N.S., and Cochrane, C.G.: Isolation and characterization of permeability factors from rabbit neutrophils. J. Exp. Med. 128: 605, 1968.CrossRefGoogle Scholar
  44. 44.
    Cochrane, C.G.: Studies on the localization of circulating antigen-antibody complexes and other macromolecules in vessels. I. Structural studies. J. Exp. Med. 118: 489, 1963.Google Scholar
  45. 45.
    Cochrane, C.G.: Studies on the localization of circulating antigen-antibody complexes and other macromolecules in vessels. II. Pathogeneic and pharmacodynamic studies. J. Exp. Med. 118: 503, 1963.PubMedCrossRefGoogle Scholar
  46. 46.
    Cochrane, C.G., and Hawkins, D.: Studies on circulating immune complexes. III. Factors governing the ability of circulating complexes to localize in blood vessels. J. Exp. Med. 127: 137, 1968.PubMedCrossRefGoogle Scholar
  47. 47.
    Wilson, C.B., and Dixon, F.J.: Quantitation of acute and chronic serum sickness in the rabbit. J. Exp. Med. 134: 7s, 1971.Google Scholar
  48. 48.
    Cochrane, C.G., and Koffler, D.: Immune complex disease in experimental animals and man. In:Advances in Immunology. F.J. Dixon and H.G. Kunkel, eds. Vol. 16. New York, Academic Press, Inc. pp. 185–264, 1973.Google Scholar
  49. 49.
    Benveniste, J., Henson, P.M., and Cochrane, C.G.: Leucocyte-dependent histamine release from rabbit platelets. The role of IgE, basophils and a ptatelet-activating factor. J. Exp. Med. 136: 1356, 1972.PubMedCrossRefGoogle Scholar
  50. 50.
    Ishizaka, K., and Campbell, D.H.: Biologic activity of soluble antigen-antibody complexes, IV. The inhibition of the skin reacitivy of soluble complexes and the PCA reaction by heterologous complexes. J. Immunol. 83: 116, 1959.PubMedGoogle Scholar

Copyright information

© Plenum Press, New York 1977

Authors and Affiliations

  • Charles G. Cochrane
    • 1
  1. 1.Department of ImmunopathologyScripps ClinicLa JollaUSA

Personalised recommendations